A detailed history of Fmr LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,801,938 shares of VERA stock, worth $113 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,801,938
Previous 3,123,268 10.29%
Holding current value
$113 Million
Previous $135 Million 24.73%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$33.72 - $48.82 $10.8 Million - $15.7 Million
-321,330 Reduced 10.29%
2,801,938 $101 Million
Q1 2024

May 13, 2024

BUY
$14.91 - $49.14 $5.2 Million - $17.1 Million
348,896 Added 12.58%
3,123,268 $135 Million
Q4 2023

Feb 13, 2024

SELL
$9.29 - $16.0 $24.8 Million - $42.7 Million
-2,670,994 Reduced 49.05%
2,774,372 $42.7 Million
Q3 2023

Nov 13, 2023

SELL
$13.71 - $19.64 $14.9 Million - $21.4 Million
-1,090,194 Reduced 16.68%
5,445,366 $74.7 Million
Q2 2023

Aug 11, 2023

BUY
$6.11 - $17.83 $4.52 Million - $13.2 Million
739,301 Added 12.75%
6,535,560 $105 Million
Q1 2023

May 11, 2023

BUY
$5.41 - $18.3 $8.91 Million - $30.2 Million
1,647,613 Added 39.71%
5,796,259 $45 Million
Q4 2022

Feb 13, 2023

BUY
$15.74 - $22.19 $1.45 Million - $2.05 Million
92,305 Added 2.28%
4,148,646 $80.3 Million
Q3 2022

Nov 10, 2022

BUY
$13.27 - $22.31 $543,937 - $914,486
40,990 Added 1.02%
4,056,341 $86.4 Million
Q2 2022

Aug 12, 2022

BUY
$12.82 - $23.4 $42,575 - $77,711
3,321 Added 0.08%
4,015,351 $54.6 Million
Q1 2022

May 13, 2022

BUY
$17.8 - $28.06 $15.4 Million - $24.3 Million
866,828 Added 27.56%
4,012,030 $94.2 Million
Q4 2021

Feb 14, 2022

BUY
$15.01 - $35.8 $87,058 - $207,639
5,800 Added 0.18%
3,145,202 $84 Million
Q3 2021

Nov 15, 2021

BUY
$13.71 - $30.6 $231,561 - $516,834
16,890 Added 0.54%
3,139,402 $54.5 Million
Q2 2021

Aug 13, 2021

BUY
$11.5 - $19.97 $35.9 Million - $62.4 Million
3,122,512 New
3,122,512 $41.4 Million

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.09B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.